Skip to main content
. Author manuscript; available in PMC: 2023 Jul 12.
Published in final edited form as: Immunity. 2022 May 27;55(7):1200–1215.e6. doi: 10.1016/j.immuni.2022.05.003

Figure 4. TCF-1+ BCL6lo/− PD-1+ CD4+ T cells are capable of superior expansion and differentiation into both Teff and Tfh cells following adoptive transfer. (See also Figure S5).

Figure 4.

(A) Experimental design of adoptive transfer of distinct PD-1+ CD4+ T cell populations from LCMV-c13 infected mice to infection-matched recipient mice for the experiments shown in (B-E). For the experiments shown in (B) and (C), 1 × 106 PD-1+ CD4+ T cells were transferred. For the experiments shown in (D) and (E), 1–2 × 106 PD-1+ CD4+ T cells containing 4.5 × 104 Tet+ cells were transferred.

(B-E) Representative flow cytometry plots showing frequencies of total donor-derived cells (B) and Tet+ donor-derived cells (D) and their expression of TCF-1 and BCL6 15 days after transfer. Pooled data from 2 experiments with n = 2–4 / group / experiment are shown in (C, E) with mean±SD and statistical analysis by One-way ANOVA. Frequencies and total numbers of donor-derived cells in (B, C) were normalized to 1 × 106 transferred donor cells, and frequencies and total numbers of Tet+ donor-derived cells in (D, E) were normalized to 4.5 × 104 Tet+ transferred donor cells.